Surgical resection of liver metastases and survival outcomes in real-life for metastatic colorectal cancer (mCRC) patients treated in front-line with cetuximab (CTX): The EREBUS cohort.

被引：0
|
作者：
Smith, Denis Michel
Cunha, Antonio Sa
Rouyer, Magali
Noize, Pernelle
Jove, Jeremy
Bignon, Emmanuelle
Le Monies, Alise
Mitry, Emmanuel
Francois, Eric
Fourrier-Reglat, Annie
机构：
[1] Univ Hosp, Bordeaux, France
[2] Ctr Hepato Biliaire, Villejuif, France
[3] Univ V Segalen, Serv Pharmacol, Bordeaux, France
[4] Univ Bordeaux Segalen, CHU Bordeaux, INSERM U657, INSERM CIC P0005, Bordeaux, France
[5] Univ Bordeaux, Serv Pharmacol, Bordeaux, France
[6] Serv Pharmacol, Bordeaux, France
[7] Inst Curie, St Cloud, France
[8] Ctr Antoine Lacassagne, Dept Med Oncol, F-06054 Nice, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14514
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Surgical resection of metastases and survival outcomes in patients with metastatic colorectal cancer (mCRC) treated with cetuximab (CTX) in the EREBUS cohort of real-life use
    Smith, D.
    Cunha, A. Sa
    Rouyer, M.
    Noize, P.
    Jove, J.
    Bignon, E.
    Monnereau, A.
    Francois, E.
    Mitry, E.
    Fourrier-Reglat, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S538 - S538
  • [2] Cetuximab in first-line treatment of metastatic colorectal cancer in a real-life setting: Preliminary results of the EREBUS cohort.
    Smith, Denis
    Rouyer, Magali
    Mitry, Emmanuel
    Monnereau, Alain
    Cunha, Antonio Sa
    Bignon, Emmanuelle
    Le Monies, Alise
    Jove, Jeremy
    Noize, P.
    Moore, Nicholas
    Fourrier-Reglat, Annie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [3] SURGICAL RESECTION OF LIVER METASTASES AND SURVIVAL OUTCOMES METASTATIC COLORECTAL CANCER (MCRC)
    Adda, Bounedjar
    Khelifa, Bendjebbar
    Haoui, Messaouda
    Kada, Boualaga
    El Mehdi, Si Ahmed
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [4] Survival outcomes and prognostic factors in real-life practice after treatment with cetuximab in 1st-line metastatic colorectal cancer in the EREBUS cohort
    Fourrier-Reglat, A.
    Rouyer, M.
    Noize, N.
    Bignon, E.
    Jove, J.
    Monnereau, A.
    Cunha, A. Sa
    Francois, E.
    Mitry, E.
    Smith, D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S554 - S554
  • [5] Use of cetuximab (CTX) in first -line therapy of metastatic colorectal cancer (mCRC): Patient characteristics, safety, and effectiveness in the EREBUS cohort
    Smith, Denis
    Rouyer, Magali
    Mitry, Emmanuel
    Francois, Eric
    Monnereau, Alain
    Cunha, Antonio Sa
    Bignon, Emmanuelle
    Le Monies, Alise
    Jove, Jeremy
    Noize, Pernelle
    Moore, Nicholas
    Fourrier-Reglat, Annie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Outcomes of cetuximab in 1st-line therapy for metastatic colorectal cancer (mCRC) according to tumor RAS/BRAF mutation (mt) status in the EREBUS cohort.
    Smith, Denis Michel
    Rouyer, Magali
    Francois, Eric
    Cunha, Antonio Sa
    Monnereau, Alain
    Yon, Edwige
    Bignon, Emmanuelle
    Droz-Perroteau, Cecile
    Noize, Pernelle
    Moore, Nicholas
    Fourrier-Reglat, Annie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] USE OF CETUXIMAB (CTX) IN 1ST-LINE THERAPY OF METASTATIC COLORECTAL CANCER (MCRC): PATIENT CHARACTERISTICS, SAFETY AND EFFECTIVENESS IN THE EREBUS COHORT
    Smith, D.
    Rouyer, M.
    Mitry, E.
    Francois, E.
    Monnereau, A.
    Sa-Cunha, A.
    Jove, J.
    Noize, P.
    Moore, N.
    Fourrier-Reglat, A.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 219 - 219
  • [8] Use of Cetuximab (CTX) in 1st-Line Therapy of Metastatic Colorectal Cancer (mCRC): Patient Characteristics, Safety and Effectiveness in the EREBUS Cohort
    Fourrier-Reglat, Annie
    Smith, Denis
    Rouyer, Magali
    Francois, Eric
    Mitry, Emmanuel
    Monnereau, Alain
    Sa-Cunha, Antonio
    Bignon, Emmanuelle
    Le Monies, Alise
    Lassalle, Regis
    Noize, Pernelle
    Moore, Nicholas
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 458 - 459
  • [9] Effectiveness of Cetuximab as First-Line Therapy for Patients With Wild-Type KRAS and Unresectable Metastatic Colorectal Cancer in Real-Life Practice: Results of the EREBUS Cohort
    Rouyer, Magali
    Francois, Eric
    Cunha, Antonio Sa
    Monnereau, Alain
    Noize, Pernelle
    Robinson, Philip
    Droz-Perroteau, Cecile
    de Sagazan, Alise Le Monies
    Jove, Jeremy
    Lassalle, Regis
    Moore, Nicholas
    Fourrier-Reglat, Annie
    Smith, Denis
    [J]. CLINICAL COLORECTAL CANCER, 2018, 17 (02) : 129 - 139
  • [10] Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohort
    Annie Fourrier-Réglat
    Denis Smith
    Magali Rouyer
    Jacques Bénichou
    Rosine Guimbaud
    Yves Bécouarn
    Olivier Bernard
    Pernelle Noize
    Nicholas Moore
    Alain Ravaud
    [J]. Targeted Oncology, 2014, 9 : 311 - 319
12345